Edges in Network
| Network | GSE16391_egf1520 - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | TAF1A |
| Upstream (Parents) |
|---|
| (<<) BCAM → TAF1A |
| (<<) CASP3 → TAF1A |
| (<<) CDH22 → TAF1A |
| (<<) EXOC3L2 → TAF1A |
| (<<) FLJ22184 → TAF1A |
| (<<) GSK3A → TAF1A |
| (<<) IL23A → TAF1A |
| (<<) IVL → TAF1A |
| (<<) LOC100131581 → TAF1A |
| (<<) LRCH4 → TAF1A |
| (<<) LRP5 → TAF1A |
| (<<) MAP6D1 → TAF1A |
| (<<) MYH14 → TAF1A |
| (<<) NRSN2 → TAF1A |
| (<<) PFDN2 → TAF1A |
| (<<) PIK3R2 → TAF1A |
| (<<) PLA2G6 → TAF1A |
| (<<) PLD3 → TAF1A |
| (<<) PPP1R15B → TAF1A |
| Downstream (Children) |
|---|
| TAF1A → CNIH4 (>>) |
| TAF1A → EVX1 (>>) |
| TAF1A → GNA11 (>>) |
| TAF1A → TMEM175 (>>) |
| TAF1A → UAP1 (>>) |
| TAF1A → VAV3 (>>) |
